Aequs Limited Grants 750,000 Stock Options Under ESOP 2025
Aequs Limited granted 750,000 Employee Stock Options under ESOP 2025 on May 11, 2026. The exercise price is ₹203.50 per option, based on the May 8, 2026, last traded price. Options have a minimum one-year vesting period and can be exercised within three years post-vesting.
This is a routine grant of employee stock options, which is a common practice for employee retention and motivation. The number of options granted is unlikely to have a significant immediate impact on the company's financials or stock price.
The grant of stock options is a standard employee incentive and does not inherently represent a positive or negative financial event for the company at this stage. The details provided are factual and procedural.
Aequs Limited (formerly Aequs Private Limited) has announced the grant of 750,000 Employee Stock Options (ESOPs) under its Aequs Employee Stock Option Plan 2025 (ESOP 2025). The Nomination and Remuneration Committee (NRC) of the Board of Directors approved this grant on May 11, 2026, to eligible employees.
The ESOP 2025 is in compliance with SEBI (Share Based Employee Benefits and Valuation) Regulations, 2021. The total number of equity shares covered by these options is 750,000, each with a face value of ₹10. The exercise price for each stock option is set at ₹203.50. This exercise price is based on the last traded price of the company's equity shares on the National Stock Exchange of India Limited as of May 8, 2026, which was the trading day immediately preceding the grant date.
Key terms of the grant include a vesting period of a minimum of one year from the grant date, with vesting scheduled as per the grant letter. Once vested, the stock options can be exercised within three years from the respective vesting date, subject to the fulfillment of vesting conditions. Upon exercise, each vested option holder will acquire an equal number of equity shares upon payment of the exercise price and applicable taxes, in accordance with the terms of ESOP 2025.
The announcement was made on May 11, 2026, and will be available on the company's website at https://www.aequs.com/investor/.
What to do with a filing like this
Aequs Limited filed this with the NSE as a statutory disclosure, categorised under designated person disclosures. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aequs Limited. Read the original for the full detail.